Page last updated: 2024-08-21

quinazolines and Canine Diseases

quinazolines has been researched along with Canine Diseases in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19902 (28.57)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (71.43)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahn, JO; Chung, JY; Jaung, WJ; Jeon, KO; Ryu, MO; Song, WJ; Won, SH; Youn, HY1
Cronise, KE; Duval, DL; Gustafson, DL; Hernandez, BG1
Kennedy, KC; Qurollo, BA; Rose, BJ; Thamm, DH1
Ben-Shlomo, A; Bruyette, D; Cooper, O; Fukuoka, H; Mamelak, A; Melmed, S; Ren, SG1
Baldi, A; Citro, G; Fanciulli, M; Spugnini, EP1
Atwell, RB1
Schiavo, DM1

Reviews

1 review(s) available for quinazolines and Canine Diseases

ArticleYear
Preclinical models in electrochemotherapy: the role of veterinary patients.
    Future oncology (London, England), 2012, Volume: 8, Issue:7

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma; Cat Diseases; Cats; Cisplatin; Dog Diseases; Dogs; Drug Evaluation, Preclinical; Electrochemotherapy; Epirubicin; Head and Neck Neoplasms; Melanoma; Mitoxantrone; Neoplasms; Quinazolines; Sarcoma; Thiophenes

2012

Other Studies

6 other study(ies) available for quinazolines and Canine Diseases

ArticleYear
Accidental afloqualone intoxication in two dogs.
    The Journal of veterinary medical science, 2018, Feb-02, Volume: 80, Issue:1

    Topics: Animals; Ataxia; Bradycardia; Dog Diseases; Dogs; Flumazenil; Male; Quinazolines; Respiratory Insufficiency; Seizures; Vomiting

2018
Identifying the ErbB/MAPK Signaling Cascade as a Therapeutic Target in Canine Bladder Cancer.
    Molecular pharmacology, 2019, Volume: 96, Issue:1

    Topics: Animals; Carcinoma, Transitional Cell; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dog Diseases; Dogs; Drug Resistance, Neoplasm; Drug Synergism; ErbB Receptors; HT29 Cells; Humans; MAP Kinase Signaling System; Mutation; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Pyridones; Pyrimidinones; Quinazolines; Urinary Bladder Neoplasms; Vemurafenib

2019
Epidermal growth factor enhances the malignant phenotype in canine mammary carcinoma cell lines.
    Veterinary and comparative oncology, 2011, Volume: 9, Issue:3

    Topics: Animals; Apoptosis; Cell Line, Tumor; Dog Diseases; Dogs; Epidermal Growth Factor; ErbB Receptors; Female; Mammary Neoplasms, Animal; Phosphorylation; Piperidines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-ret; Quinazolines; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2

2011
EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas.
    The Journal of clinical investigation, 2011, Volume: 121, Issue:12

    Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Adrenocorticotropic Hormone; Animals; Cell Line, Tumor; Corticosterone; Dog Diseases; Dogs; Drug Screening Assays, Antitumor; ErbB Receptors; Gefitinib; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Nude; Molecular Targeted Therapy; Neoplasm Transplantation; Pituitary ACTH Hypersecretion; Pro-Opiomelanocortin; Promoter Regions, Genetic; Protein Kinase Inhibitors; Quinazolines; Secretory Rate; Tumor Burden

2011
The use of alpha blockade in the treatment of congestive heart failure associated with dirofilariasis and mitral valvular incompetence.
    The Veterinary record, 1979, Feb-10, Volume: 104, Issue:6

    Topics: Animals; Digoxin; Dirofilariasis; Dog Diseases; Dogs; Female; Furosemide; Heart Failure; Male; Mitral Valve Insufficiency; Prazosin; Quinazolines

1979
Retinopathy from administration of an imidazo quinazoline to beagles.
    Toxicology and applied pharmacology, 1972, Volume: 23, Issue:4

    Topics: Animals; Dog Diseases; Dogs; Female; Imidazoles; Male; Quinazolines; Retina; Retinal Diseases; Time Factors

1972